ABL2 and HCK

  • Number of citations of the paper that reports this interaction (PMID 12748290)
  • 39
  • Data Source:
  • BioGRID (two hybrid)
  • HPRD (in vitro, in vivo)

ABL2

HCK

Gene Name ABL proto-oncogene 2, non-receptor tyrosine kinase HCK proto-oncogene, Src family tyrosine kinase
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
  • Inflammatory bowel disease ( 23128233)
Protein-Protein Interactions 25 interactors: ABL1 BCR C15orf48 CAT CRK DOK1 EGFR EPHB2 ERBB2 ERBB3 ERBB4 FBXO38 GPX1 GRB2 HCK MAP3K10 NEDD4 NEDD4L OIP5 PSMA7 RIN1 SIVA1 SORBS2 TPD52L1 TRIP10 69 interactors: ABL1 ABL2 ACTB ADAM15 AGK APP ARRB1 ASAP1 BCAR1 BCR BTK C2orf44 CBL CCR3 CD2AP CHST15 CREBBP CSF2RB CSF3R CSK DNM2 DOK1 DOK2 ELMO1 ERBB3 EVL FASLG FCGR1A FCGR2A GOPC HNRNPK IL6ST INPP5D IRF2BPL KHDRBS1 KIT KRT40 KRTAP10-9 LCP2 MAP4K5 MTUS2 NOTCH2NL PAK2 PECAM1 PIK3CB PIK3R1 PIK3R2 PLAUR PLCG1 PLCG2 RAPGEF1 RASA1 RASA3 RPL10 SF3B3 SH3BP1 SH3KBP1 SKAP2 SOS1 SPRR2A STAT3 TNK2 TRPV4 TSG101 UNC119 VAV1 WAS WIPF1 WNT2
Entrez ID 27 3055
HPRD ID 01259 00796
Ensembl ID ENSG00000143322 ENSG00000101336
Uniprot IDs P42684 A8K4G3 P08631
PDB IDs 2ECD 2KK1 2XYN 3GVU 3HMI 3ULR 4EIH 1AD5 1BU1 1QCF 2C0I 2C0O 2C0T 2HCK 2HK5 2OI3 2OJ2 3HCK 3NHN 3RBB 3REA 3REB 3VRY 3VRZ 3VS0 3VS1 3VS2 3VS3 3VS4 3VS5 3VS6 3VS7 4HCK 5HCK
Enriched GO Terms of Interacting Partners?
Tagcloud ?
abl1  adding  amenable  charities  crizotinib  crlf2  csf1r  dasatinib  epor  etv6  flt3  funded  fusions  il7r  lebanese  lymphoblastic  ntrk3  pdgfrb  ph  philadelphia  ptk2b  rearrangements  responsiveness  ruxolitinib  sh2b3  syrian  tslp  tyk2  undefined 
32dcl3  32p  antisera  cbl  eliminated  engagement  fusion  fyn  gst  immunoprecipitated  immunoprecipitates  implying  lyn  lysate  lzip  nb2  nonphosphorylated  p85  phosphatidylinositol  phosphorylate  phosphoserine  phosphothreonine  phosphotyrosine  proline  sh2  sh3  thymoma  tyr731  yeam 
Tagcloud (Difference) ?
abl1  adding  amenable  charities  crizotinib  crlf2  csf1r  dasatinib  epor  etv6  flt3  funded  fusions  il7r  lebanese  lymphoblastic  ntrk3  pdgfrb  ph  philadelphia  ptk2b  rearrangements  responsiveness  ruxolitinib  sh2b3  syrian  tslp  tyk2  undefined 
32dcl3  32p  antisera  cbl  eliminated  engagement  fusion  fyn  gst  immunoprecipitated  immunoprecipitates  implying  lyn  lysate  lzip  nb2  nonphosphorylated  p85  phosphatidylinositol  phosphorylate  phosphoserine  phosphothreonine  phosphotyrosine  proline  sh2  sh3  thymoma  tyr731  yeam 
Tagcloud (Intersection) ?